HSPA5 and Parkinson disease: The hypothesis derived from both paradigms is that the neuroprotective effects associated with the activation of the CB1 receptor in experimental ALS [18,19,20], but not those found in experimental PD [15,16,17], might be modulated by BiP function, a notion that will require additional research.